Coronary Calcium Score Explained: CAC vs Full-Body MRI
A clinical explanation of the coronary artery calcium score, how it differs from whole-body MRI, and why the two studies are complementary rather than competitive.
By CVI Peak Prevention Editorial Team · CVI Peak Prevention Program
One of the most common questions in preventive imaging is whether a whole-body MRI covers what a coronary calcium score does. It does not. The two studies use different physics, answer different clinical questions, and belong to different evidence categories. For patients in Newport Beach, Corona del Mar, or elsewhere in Orange County considering a preventive imaging plan, understanding why both exist is the starting point for a reasonable program design.
What a Coronary Artery Calcium Score Is
The coronary artery calcium (CAC) score, also called the Agatston score, is produced by a low-dose, non-contrast, ECG-gated cardiac CT. The scan takes a few seconds of actual acquisition, with the full appointment generally under fifteen minutes. Software identifies radiopaque calcium within the coronary arteries and computes a weighted score.
The score has a well-established evidence base. Higher CAC scores correlate with increased burden of atherosclerotic coronary plaque and with increased risk of future cardiovascular events. The 2019 American College of Cardiology and American Heart Association Guideline on the Primary Prevention of Cardiovascular Disease gives CAC a Class IIa recommendation for refining the decision to initiate statin therapy in selected intermediate-risk adults when the decision is otherwise uncertain. Guideline-directed application of CAC for primary prevention (JACC: Cardiovascular Imaging) summarizes the guideline framework.
General interpretive patterns:
- CAC = 0. Lower short-term cardiovascular event risk in most intermediate-risk adults. In many cases, the decision to start a statin is deferred.
- CAC 1 to 99. Mild calcified plaque burden. Typically supports statin initiation in selected patients, particularly those over fifty-five.
- CAC 100 or greater. Significant calcified plaque burden. Generally supports statin therapy and often aspirin consideration depending on other risk factors, per guideline.
CAC is a population-risk refinement tool, not a diagnostic test for coronary artery disease. It does not visualize soft plaque, does not quantify stenosis, and does not replace a coronary CT angiogram or catheter angiography when those studies are clinically indicated.
What Whole-Body MRI Does
Whole-body MRI is a soft-tissue-oriented screening modality. It may help visualize structural abnormalities across the brain, spine, abdomen, pelvis, and musculoskeletal system without ionizing radiation. For a fuller description see our article on what whole-body MRI can and cannot detect.
Whole-body MRI does not produce a coronary calcium score. It cannot. The physics of MRI do not visualize small calcifications in coronary arteries the way CT does, and the temporal and spatial resolution needed to quantify coronary plaque is not part of a whole-body screening protocol. Attempts to substitute one study for the other — in either direction — are clinically unsound.
Why the Two Are Complementary
The clearest way to frame this is by the organ system each modality covers well.
CAC covers what MRI does not: coronary calcified plaque burden, quantified in a clinically actionable score that has guideline-backed utility for preventive cardiology decisions.
MRI covers what CAC does not: soft-tissue structural screening across the brain, spine, abdomen, pelvis, and musculoskeletal system, without ionizing radiation.
A preventive imaging plan that includes both modalities is not redundant. It is complementary. Both CVI's Reserve tier and several comparable programs in the market integrate MRI with low-dose CT and coronary calcium scoring for this reason — the two studies answer non-overlapping clinical questions and produce independent inputs that a thoughtful physician can use to inform a risk-reduction plan.
Radiation Considerations
A CAC scan typically delivers approximately 1 to 1.5 mSv of effective radiation dose with modern low-dose protocols. That is in the same range as a screening mammogram and considerably less than a contrast-enhanced abdominal CT. For context, the average annual background radiation exposure in the United States is approximately 3 mSv.
Whole-body MRI delivers no ionizing radiation. For annually repeated screening, that difference matters. It is also the reason that many providers position the MRI as the primary recurring baseline, with CAC performed at longer intervals or as indicated by risk profile.
Cost and Access
CAC is one of the lower-cost preventive imaging studies available. Self-pay rates in the United States commonly fall between approximately $100 and $400 depending on facility and geography. Some insurance plans cover CAC in selected patients when clinically indicated, though many pay out-of-pocket.
Whole-body MRI pricing is substantially higher, reflecting scan time, read time, and the sequence-depth required. See our 2026 pricing breakdown for Orange County for current market ranges.
At CVI, CAC is included at the Reserve tier and available as an optional add-on at the Signature and Elite tiers. The integration is intentional: patients pursuing an annual MRI baseline often benefit from a one-time or infrequent CAC measurement to refine cardiovascular risk.
What CAC Does Not Do
It is worth being explicit about CAC's limits, because any elective preventive study should be presented with its limitations up front.
- CAC measures calcified plaque. It does not quantify soft, non-calcified plaque. Younger patients with early atherosclerotic disease may have a CAC score of zero while still carrying non-calcified plaque burden.
- CAC is a risk-refinement tool, not a diagnostic test for acute coronary syndromes or symptomatic coronary disease. Patients with chest pain or ischemic symptoms require a different diagnostic pathway.
- CAC is most useful in intermediate-risk adults. In very low-risk or very high-risk populations, the score adds less marginal decision value because the statin decision is often already clear from the ASCVD risk estimator.
- CAC does not quantify stenosis. A high CAC score does not automatically mean flow-limiting disease, and a low CAC score does not automatically mean the coronary tree is patent on angiography.
How CVI Integrates CAC
CVI's Reserve tier includes coronary calcium scoring alongside whole-body MRI and low-dose CT of the thorax, abdomen, and pelvis, read by the dual-specialist model (neuroradiology plus MSK). The integration reflects the clinical reality that cardiovascular risk and structural soft-tissue findings are independent axes of preventive information that benefit from being generated in one coordinated visit, reviewed by subspecialty radiologists, and discussed in a physician review session. Tier architecture and included modalities are detailed on the CVI program overview.
For patients at the Signature or Elite tier who wish to add CAC, the pathway is straightforward and can usually be coordinated in the same imaging visit. Follow-through after the scan is designed to ensure that CAC results, like all findings, are delivered with appropriate physician context and not handed off in a PDF.
Practical Takeaways
- Coronary calcium score and whole-body MRI are complementary studies, not substitutes.
- CAC has guideline-backed utility for primary-prevention statin decisions in intermediate-risk adults.
- Whole-body MRI does not produce a usable coronary calcium score and does not replace cardiac-specific imaging.
- Both studies produce incidental findings and should be read by subspecialty-trained radiologists and reviewed with a licensed physician.
- For executives building an annual preventive imaging plan, integrating both modalities is a reasonable strategy. An MRI-only program should not be relied upon for cardiovascular risk refinement.
Disclaimer
This article is educational and is not medical advice. CAC scoring and whole-body MRI are elective preventive imaging studies with published limitations and false-positive and false-negative rates. No finding on either study should be interpreted without review by a licensed physician who knows the patient's clinical history. CVI Peak Prevention Program is an elective preventive imaging service and does not create a physician-patient relationship. Symptomatic chest pain, shortness of breath, or suspected acute coronary syndrome requires emergency care — call 911 or go to the nearest emergency department. See CVI's full disclaimer.